Agricultural Inputs
Compare Stocks
2 / 10Stock Comparison
NTR vs SMG
Revenue, margins, valuation, and 5-year total return — side by side.
Agricultural Inputs
NTR vs SMG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Agricultural Inputs | Agricultural Inputs |
| Market Cap | $35.51B | $3.65B |
| Revenue (TTM) | $26.90B | $3.35B |
| Net Income (TTM) | $2.27B | $90M |
| Gross Margin | 31.1% | 31.0% |
| Operating Margin | 13.4% | 11.7% |
| Forward P/E | 13.0x | 14.3x |
| Total Debt | $12.93B | $2.38B |
| Cash & Equiv. | $700M | $37M |
NTR vs SMG — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Nutrien Ltd. (NTR) | 100 | 217.1 | +117.1% |
| The Scotts Miracle-… (SMG) | 100 | 44.1 | -55.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NTR vs SMG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NTR carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 5.3%, EPS growth 248.5%, 3Y rev CAGR -10.3%
- 64.0% 10Y total return vs SMG's 34.9%
- Lower volatility, beta -0.07, Low D/E 51.1%, current ratio 1.34x
SMG is the clearest fit if your priority is income & stability.
- Dividend streak 0 yrs, beta 1.10, yield 4.2%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 5.3% revenue growth vs SMG's -3.9% | |
| Value | Lower P/E (13.0x vs 14.3x) | |
| Quality / Margins | 8.4% margin vs SMG's 2.7% | |
| Dividends | 3.0% yield, 8-year raise streak, vs SMG's 4.2% | |
| Momentum (1Y) | +34.6% vs SMG's +19.3% | |
| Efficiency (ROA) | 4.3% ROA vs SMG's 2.9%, ROIC 8.0% vs 13.3% |
NTR vs SMG — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
NTR vs SMG — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
NTR leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
NTR is the larger business by revenue, generating $26.9B annually — 8.0x SMG's $3.4B. NTR is the more profitable business, keeping 8.4% of every revenue dollar as net income compared to SMG's 2.7%. On growth, NTR holds the edge at +6.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $26.9B | $3.4B |
| EBITDAEarnings before interest/tax | $6.0B | $466M |
| Net IncomeAfter-tax profit | $2.3B | $90M |
| Free Cash FlowCash after capex | $2.0B | $358M |
| Gross MarginGross profit ÷ Revenue | +31.1% | +31.0% |
| Operating MarginEBIT ÷ Revenue | +13.4% | +11.7% |
| Net MarginNet income ÷ Revenue | +8.4% | +2.7% |
| FCF MarginFCF ÷ Revenue | +7.4% | +10.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +6.8% | -15.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +4.2% | -78.5% |
Valuation Metrics
NTR leads this category, winning 3 of 5 comparable metrics.
Valuation Metrics
At 15.6x trailing earnings, NTR trades at a 39% valuation discount to SMG's 25.4x P/E. On an enterprise value basis, NTR's 7.5x EV/EBITDA is more attractive than SMG's 13.8x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $35.5B | $3.6B |
| Enterprise ValueMkt cap + debt − cash | $47.7B | $6.0B |
| Trailing P/EPrice ÷ TTM EPS | 15.57x | 25.45x |
| Forward P/EPrice ÷ next-FY EPS est. | 12.97x | 14.34x |
| PEG RatioP/E ÷ EPS growth rate | 0.38x | — |
| EV / EBITDAEnterprise value multiple | 7.49x | 13.82x |
| Price / SalesMarket cap ÷ Revenue | 1.30x | 1.07x |
| Price / BookPrice ÷ Book value/share | 1.42x | — |
| Price / FCFMarket cap ÷ FCF | 17.43x | 13.32x |
Profitability & Efficiency
SMG leads this category, winning 4 of 7 comparable metrics.
Profitability & Efficiency
On the Piotroski fundamental quality scale (0–9), NTR scores 8/9 vs SMG's 7/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +9.1% | — |
| ROA (TTM)Return on assets | +4.3% | +2.9% |
| ROICReturn on invested capital | +8.0% | +13.3% |
| ROCEReturn on capital employed | +9.8% | +17.4% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 7 |
| Debt / EquityFinancial leverage | 0.51x | — |
| Net DebtTotal debt minus cash | $12.2B | $2.3B |
| Cash & Equiv.Liquid assets | $700M | $37M |
| Total DebtShort + long-term debt | $12.9B | $2.4B |
| Interest CoverageEBIT ÷ Interest expense | 5.44x | 3.08x |
Total Returns (Dividends Reinvested)
NTR leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in NTR five years ago would be worth $14,121 today (with dividends reinvested), compared to $3,161 for SMG. Over the past 12 months, NTR leads with a +34.6% total return vs SMG's +19.3%. The 3-year compound annual growth rate (CAGR) favors NTR at 7.6% vs SMG's -0.8% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +17.7% | +6.9% |
| 1-Year ReturnPast 12 months | +34.6% | +19.3% |
| 3-Year ReturnCumulative with dividends | +24.5% | -2.5% |
| 5-Year ReturnCumulative with dividends | +41.2% | -68.4% |
| 10-Year ReturnCumulative with dividends | +64.0% | +34.9% |
| CAGR (3Y)Annualised 3-year return | +7.6% | -0.8% |
Risk & Volatility
Evenly matched — NTR and SMG each lead in 1 of 2 comparable metrics.
Risk & Volatility
NTR is the less volatile stock with a -0.07 beta — it tends to amplify market swings less than SMG's 1.10 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.07x | 1.10x |
| 52-Week HighHighest price in past year | $85.36 | $72.35 |
| 52-Week LowLowest price in past year | $53.03 | $52.00 |
| % of 52W HighCurrent price vs 52-week peak | +86.5% | +86.9% |
| RSI (14)Momentum oscillator 0–100 | 59.7 | 41.3 |
| Avg Volume (50D)Average daily shares traded | 3.7M | 948K |
Analyst Outlook
Evenly matched — NTR and SMG each lead in 1 of 2 comparable metrics.
Analyst Outlook
Wall Street rates NTR as "Buy" and SMG as "Buy". Consensus price targets imply 14.6% upside for SMG (target: $72) vs 14.1% for NTR (target: $84). For income investors, SMG offers the higher dividend yield at 4.18% vs NTR's 3.01%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $84.25 | $72.00 |
| # AnalystsCovering analysts | 33 | 17 |
| Dividend YieldAnnual dividend ÷ price | +3.0% | +4.2% |
| Dividend StreakConsecutive years of raises | 8 | 0 |
| Dividend / ShareAnnual DPS | $2.22 | $2.63 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.6% | +0.5% |
NTR leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). SMG leads in 1 (Profitability & Efficiency). 2 tied.
NTR vs SMG: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is NTR or SMG a better buy right now?
For growth investors, Nutrien Ltd.
(NTR) is the stronger pick with 5. 3% revenue growth year-over-year, versus -3. 9% for The Scotts Miracle-Gro Company (SMG). Nutrien Ltd. (NTR) offers the better valuation at 15. 6x trailing P/E (13. 0x forward), making it the more compelling value choice. Analysts rate Nutrien Ltd. (NTR) a "Buy" — based on 33 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NTR or SMG?
On trailing P/E, Nutrien Ltd.
(NTR) is the cheapest at 15. 6x versus The Scotts Miracle-Gro Company at 25. 4x. On forward P/E, Nutrien Ltd. is actually cheaper at 13. 0x.
03Which is the better long-term investment — NTR or SMG?
Over the past 5 years, Nutrien Ltd.
(NTR) delivered a total return of +41. 2%, compared to -68. 4% for The Scotts Miracle-Gro Company (SMG). Over 10 years, the gap is even starker: NTR returned +64. 0% versus SMG's +34. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NTR or SMG?
By beta (market sensitivity over 5 years), Nutrien Ltd.
(NTR) is the lower-risk stock at -0. 07β versus The Scotts Miracle-Gro Company's 1. 10β — meaning SMG is approximately -1618% more volatile than NTR relative to the S&P 500.
05Which is growing faster — NTR or SMG?
By revenue growth (latest reported year), Nutrien Ltd.
(NTR) is pulling ahead at 5. 3% versus -3. 9% for The Scotts Miracle-Gro Company (SMG). On earnings-per-share growth, the picture is similar: The Scotts Miracle-Gro Company grew EPS 504. 9% year-over-year, compared to 248. 5% for Nutrien Ltd.. Over a 3-year CAGR, SMG leads at -4. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NTR or SMG?
Nutrien Ltd.
(NTR) is the more profitable company, earning 8. 4% net margin versus 4. 3% for The Scotts Miracle-Gro Company — meaning it keeps 8. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NTR leads at 14. 5% versus 10. 5% for SMG. At the gross margin level — before operating expenses — NTR leads at 31. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NTR or SMG more undervalued right now?
On forward earnings alone, Nutrien Ltd.
(NTR) trades at 13. 0x forward P/E versus 14. 3x for The Scotts Miracle-Gro Company — 1. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for SMG: 14. 6% to $72. 00.
08Which pays a better dividend — NTR or SMG?
All stocks in this comparison pay dividends.
The Scotts Miracle-Gro Company (SMG) offers the highest yield at 4. 2%, versus 3. 0% for Nutrien Ltd. (NTR).
09Is NTR or SMG better for a retirement portfolio?
For long-horizon retirement investors, Nutrien Ltd.
(NTR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 07), 3. 0% yield). Both have compounded well over 10 years (NTR: +64. 0%, SMG: +34. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NTR and SMG?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: NTR is a mid-cap deep-value stock; SMG is a small-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.